Table of Contents (Version-2026)
Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Novel Product Launch/Approval
- PEST Analysis
- Awareness Strategy
- Reimbursement Scenario
- Typhoid Fever Vaccines Shortage
- Clinical Trial Analysis
- Countries with High Number of Incidents of Snake Bites
- Market Entry Challenges
- Market Dynamics
Global Typhoid Fever Vaccines Market, By Vaccine Type, 2026 – 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 – 2033
- Segment Trends
- Live Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Capsular Polysaccharide Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Introduction
Global Typhoid Fever Vaccines Market, By Route of Administration, 2026 – 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 – 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Parental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
- Introduction
Global Typhoid Fever Vaccines Market, By Region, 2026 – 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026–2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi SA
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Med Pvt. Ltd.
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PT Bio Farma
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PaxVax, Inc.
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai Institute of Biological Products Co., Ltd.
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prokarium
- Company Introduction
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline Plc.
Section
- References
- Research Methodology
- About Us and Sales Contact
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients


